Is Pentosan Polysulfate Sodium compatible with breastfeeding? Do we have alternatives for Pentosan Polysulfate Sodium?

Pentosan Polysulfate Sodium

January 24, 2017 (Very Low Risk)

Sulfated polysaccharide of plant origin with anticoagulant and fibrinolytic properties similar to heparin. Topical, oral and parenteral administration (subcutaneous, intramuscular or intravenous).
Orally used for pain relief of the urinary tract on interstitial cystitis.
Topically used on superficial venous disorders, hemorrhoids and hematomas.

At latest update relevant published data on its excretion into breast milk were not found.

Because of a high molecular weight, excretion into breastmilk in significant amounts seems very unlikely.
A low or not at all oral bioavailability (Faaij 1999, Simon 2005) makes it seems difficult the pass into the infant’s plasma through the breast milk ingested, except for premature infants and immediate neonatal period, in which there may be an increased intestinal permeability.

Do not apply it on the chest to prevent the infant from ingesting it; if necessary, do it after a feeding and clean it up thoroughly with water before the next one.

Alternatives

We do not have alternatives for Pentosan Polysulfate Sodium since it is relatively safe.

Very Low Risk

Compatible. Not risky for breastfeeding or infant.

Low Risk

Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.

High Risk

Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.

Very High Risk

Not recommended. Cessation of breastfeeding or alternative.

Synonyms

  • Sodium Xylanpolysulphate

Writings

  • πεντοσάνο-πολυθειϊκό νάτριο (Greek)
  • بانتوسان بوليسولفات صوديوم (Arabic)
  • Натрия Пентозана Полисульфат (Cyrillic)
  • 木聚硫钠 (Chinese)
  • ペントサン多硫酸ナトリウム (Japanese)
  • SP-54 (Experimental code/s)

References

  1. AEMPS. Pentosano. Ficha técnica. 2007 Full text (in our servers)
  2. Simon M, McClanahan RH, Shah JF, Repko T, Modi NB. Metabolism of [3H]pentosan polysulfate sodium (PPS) in healthy human volunteers. Xenobiotica. 2005Abstract
  3. FDA. Pentosan. Prescribing Information. 2002 Full text (in our servers)
  4. Faaij RA, Srivastava N, van Griensven JM, Schoemaker RC, Kluft C, Burggraaf J, Cohen AF. The oral bioavailability of pentosan polysulphate sodium in healthy volunteers. Eur J Clin Pharmacol. 1999Abstract
  5. Peters M, Witvrouw M, De Clercq E, Ruf B. Pharmacokinetics of intravenous pentosan polysulphate (HOE/BAY 946) in HIV-positive patients. AIDS. 1991Abstract
  6. Dawes J, Prowse CV, Pepper DS. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Thromb Res. 1986Abstract